Mandate

Vinge has advised Gränges in connection with its rights issue

Vinge has advised Gränges AB (publ) in connection with a fully guaranteed rights issue of approximately SEK 1.7 billion before transaction costs.

The purpose of the rights issue is to finance the acquisition of Aluminium Konin, maintain Gränges’ financial strength and to finance future growth investments in line with Gränges’ strategy. The new shares subscribed for with subscription rights are expected to be admitted to trading on Nasdaq Stockholm on December 22, 2020.

Gränges is a leading global supplier of rolled aluminium products for heat exchanger applications, speciality packaging and niche markets. The company develops, produces and markets advanced materials that enhance efficiency in the customers’ manufacturing process and the performance of the final products. The company’s geographical markets are Europe, Asia and the Americas with production facilities in all three regions and a total annual capacity of 560,000 metric tonnes. Gränges has 2,400 employees and net sales of SEK 13 billion. The share is listed on Nasdaq Stockholm.

Vinge’s team primarily consisted of Jesper Schönbeck, Rikard Lindahl, Linnéa Sellström, Stephanie Stiernstedt, Anders Sundin Lundberg and Lorin Arabi (Capital Markets and Public M&A), Pauline Lagerstrand and Rebecka Målquist (Banking and Finance) as well as Maria Schultzberg and Henrik Wastenson (Tax).

Related

Vinge advises OsteoCentric on the public offer for Integrum

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025